Biography
Prof. Aizhong Liu, has graduated from Hunan Medical University in 1987. He has received his professional doctorate of Epidemiology and Biostatistics in 2005. During 2005-2008 he pursued his post doctoral research in Queen’s University, Canada. Affiliations: He is serving as the chairman of Community Health Management Committee and standing Professional Committee of Epidemiology in Hunan Province. He is also an Executive Director in Hunan Province Health Management Association and Hunan Province Children’s Health management committee. He also holds the privilege as Vice-chairman for Hunan Province Clinical epidemiology and evidence based medicine professional committee. He has also served as National Occupational Skill Testing assessor of Health management division. He is also the Deputy Editor of “U.S Chinese Journal of Lymphology and Oncologyâ€, “Psychiatry research "," Chinese Journal of Epidemiology "," Evaluation expert - South University "(Medical Sciences), Communication Editorial -" China Epidemiology ",Editorial Board Member -" Journal of Nanchang University (Medical Sciences) "," Chinese medicine "," Modern Medicine "and" Chinese Journal of Clinical meta "
Research Interest
Dr. Liu’s research interests are environmental epidemiology, injury epidemiology, clinical epidemiology, comprehensive assessment of treatment outcomes, and the utilization of advanced analytic tools (e.g., Markov models, Kaplan-Meier method, Log-rank test, COX regression models, and TOPSIS method) for complex population health databases.
Biography
Dr. Verma is Chief of the Epidemiology and Genomics Research Program's (EGRP) Methods and Technologies Branch (MTB), and oversees its research portfolio and initiatives that focus on methods to address epidemiologic data collection, study design and analysis, and to modify technological approaches developed in the context of other research endeavors for use as biomarkers and methods to understand cancer susceptibility. He is responsible for stimulating EGRP-funded research on epigenetic approaches in cancer epidemiology and has been instrumental in developing epigenetics research for NIH as a whole. Dr. Verma helped to develop a Request for Applications (RFA) on Environmental Influences on Epigenetics with the National Institute of Environmental Health Sciences (NIEHS) and represents the Division of Cancer Control and Population Sciences (DCCPS), in NIH's Roadmap Initiative on EpigeneticsExternal Web Site Policy. He helped develop an RFA on Comparative Systems Genetics of Cancer with NCI's Division of Cancer Biology (DCB), and is known within the extramural research community as an EGRP Program Director for Program Announcements (PAs) on Small Grants for Cancer Epidemiology and Pilot Studies in Pancreatic Cancer. He also organized a workshop to explore developing a concept for a research initiative on mitochondrial DNA and cancer epidemiology. Dr. Verma was, and continues to be, a co-Program Director for initiatives in gene-environment interactions in cancer etiology, including the Breast and Prostate Cancer and Hormone-Related Variants Cohort Consortium (BPC3), which is a collaborative project to pool data and biospecimens from a group of large prospective cancer epidemiology cohorts. Dr. Verma joined EGRP as a Program Director in 2004. In 2005, he was appointed Acting Chief of EGRP's former Analytic Epidemiology Research Branch (AERB). When EGRP reorganized in 2007, he was appointed Acting Chief of MTB and of the Host Susceptibility Factors Branch (HSFB), for which he served as Acting Chief through 2008. Before joining EGRP, he was a Program Director in NCI's Division of Cancer Prevention (DCP), where he worked in the areas of biomarkers, early detection, risk assessment, and prevention. He also was Coordinator of DCP's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. He was on the faculty in the Biochemistry Department of Georgetown University before joining NIH.
Research Interest
Biomarkers,Epigenetics,Epidemiology Technologies Proteomics,MicroRNA,Methylation,Mitochondria Nanotechnology,Risk Assessment,Susceptibility Factors,Systems Genetics,Metabolomics
Biography
Dr Diana Anderson has published over 400 papers; edited/authored 8 books; series editor for “Current Toxicology†J Wiley and Sons and “Issues in Toxicology†Royal Society of Chemistry; editor of 4 special issues in Mutation Research, 1 of Enviromental and Molecular Mutagenesis, 3 of Teratogenesis, Carcinogenesis and Mutagenesis and part of one for Mutagenesis.
Research Interest
cancer, oxygen radicals, human biomonitoring, unbalanced precursor pools, dietary imbalance, male-mediated developmental defects, nanotoxicology, general toxicology